Ethical and Legal Aspects of Translational Medicine (EURAT)

The EURAT platform exists since 2011 and was founded as an interdisciplinary and inter-institutional group to ethically accompany ethical and legal questions of genome sequencing and translation of new technologies into the clinic.

EURAT is formed by scholars from Heidelberg University, Heidelberg University Hospital, the German Cancer Research Center (DKFZ), the National Center for Tumor Diseases (NCT), and the Hopp-Kindertumorzentum (KiTZ), who come from both the normative sciences (ethics, law) and the life sciences (biology, medicine, etc.).

EURAT is funded by the German Cancer Research Center. In the past, funding was provided by the Marsilius Kolleg.